Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2026-02-05 @ 8:52 PM
Study NCT ID:
NCT04659733
Status:
UNKNOWN
Last Update Posted:
2020-12-09
First Post:
2020-12-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children
Sponsor:
Yizhuo Zhang
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Sarcoma | View |
Keywords: